CD274 and neoplasm: here is multiple evidence that multiple approaches, including chemotherapy, radiation therapy, and angiogenesis inhibitors, can synergistically target PD-1/PD-L1 through various pathways, such as promoting tumor antigen release, antigen presenting cell function, or effector activity (33–39).